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Background: Different studies have indicated that urinary tract infections frequently occur in both community and
hospital environments and are of the most common bacterial infections in humans. the outcomes of urinary tract
infections are increased hospitalization, increased direct patient costs and mortality. In Dessie, the prevalence of the
commmon pathogens and antibiotic susceptibility pattern is not well studied sofar. Thus, the aim of this study is to
address these gaps in the study area.
Methods: Retrospective study was conducted in Dessie regional health reseacrh laboratory from January 1-March
31, 2012. All culture and antibiotic susceptibility test results of patients’ diagnosed with UTI from September 2002 to
September 2011 G.C were included in the study. Data were abstracted using structured questionnaires and finally,
entered into SPSS Windows version 16.0, and descriptive statistics was generated to meet the study objective.
Results: During the last ten years 680 (27.35%) bacteria were isolated in the regional laboratory. The most
commonly isolated were E. coli 410 (60.29%), Pseudomonas species 59 (8.68%), Proteus species 53 (7.79%), S. aurous
50 (7.35%) and Klebsiella species 40 (5.88%). The E.coli were susceptible to Nitrofurantoin 43 (89.6%), furantoin 124
(87.3%), Nalidixic acid 91 (86.7%), kanamycin 116 (80%) & ciprofloxacin 66 (71.7%) but were almost resistant to
Ampicillin, tetracycline, & trimethoprim-sulfamethoxazole. Similarly Pseudomonas and proteus species were resistant
to almost all antibiotics except Gentamycin.
Conclusion: The E.coli, pseudomonas and proteus species were the commonly isolated bacteria in the regional
health research laboratory. A majority of isolated bacterial microbes were resistant to antibiotics commonly used in
clinical practices and generally available in the local economy without prescription. Culture results are necessary
before initiating antibiotics.
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Urinary tract infections (UTI) are one of the most com-
mon bacterial infections in the human urinary system.
Most of these infections involve the lower urinary tract,
namely the bladder and the urethra. UTIs are much more
common in elderly than younger individuals for a variety
of reasons, and frequently occur both in community and
hospital environments [1,2]. Urethritis, cystitis, acute pylo-
nephritis, prostatitis, and intra -renal and peri-nephric* Correspondence: asratagl@yahoo.com
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unless otherwise stated.abscesses are the common types of UTIs [1-3]. The
symptoms of UTI are non-specific and may lead to
vague diagnosis [3,4].
Women are at three times greater risk for UTI than
men because of short, straight anatomy of the urethra,
and termination of female urethra beneath the labia
resulting in colonization by colonic gram-negative ba-
cilli [1,3,5]. There are different pathogens that cause
UTI [1,3]. The E.coli, Klebsiella species, P.aeruginosa,
and Enterococcus species were the most common bacterial
pathogens isolated from the urinary tracts of infected pa-
tients [6-8]. UTIs are usually listed among common health
care associated infections that occur mostly in health carel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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onmental reasons [9-12].
The antibiotic sensitivity patterns of bacteria isolated
from urinary tracts differ for different bacteria and anti-
biotics [6,7,13] with sensitivity to the Quinolones being
usual while resistance is often seen to nitrofurantoin;
Ampicillin and Cotrimoxazole. So far, E.coli has been re-
ported as the most resistant microorganism almost for
all antibiotics including Quinolones [6,14] leading to re-
current infections [15,16]. Irrational drug use such as
long term use and low-dose antibiotic use due to lack of
protocol for antibiotic use and empiric therapy due to
lack of laboratory facility to determine sensitivity are the
possible reasons for resistance and thus, recurrent infec-
tions and complicated UTIs [14-16].
Hence reporting common etiologic agents and respect-
ive antibiotic sensitivity is crucial for stakeholders to
search for preventive and control measures against anti-
biotic resistance. There are few data regarding etiologic
agents and respective antibiotic sensitivity in our country
except limited studies on antimicrobial sensitivity. Ac-
cording to this study the overall prevalence of antibiotic
resistance ranges from 65% to 72% [17,18]. However, to
our knowledge there was no published data on etiologic
agents and antibiotic sensitivity in South Wollo. Thus,
the aim of this study is to determine common etiologic
agents and respective antibiotic sensitivity in an undevel-
oped country with some effective health care, as is com-
mon to many areas of the world.
Methods
Study area
This retrospective study was conducted in Dessie regional
health research laboratory from January 1 to March 31,
2012 G.C. Dessie regional health research laboratory is
located in Dessie town, Amhara region, North-East
Ethiopia, 401 km from capital city, Addis Ababa. It is
the only regional health research laboratory in North-East
Amhara region serving laboratory requests from differ-
ent areas of the region both governmental and non-
governmental health organizations and from community
too. According to Dessie town health administrative office,
in the town there are 16 governmental health institutions
(1 referral hospital, 1 primary hospital, 8 health centers
and 6 health posts), and private health institutions (3
general hospitals, 6 higher clinics, 23 medium clinics,
15 pharmacies, and 24 drug stores).
Study subjects
All patient data recorded on patient recording books
from September 2002 to September 2011 G.C in the la-
boratory were included in the study. Similarly, the anti-
biotic sensitivity for the specific pathogen isolated was
included in the study. Data were collected using astructured data collection format developed by the
principal investigators. All the information including
culture results and antibiotic sensitivity for isolated
pathogens were collected.
Laboratory diagnostic methods
The records data showed mid-stream (“clean catch”)
urine specimen collected from each patient. Bacterial
isolation and identification was performed according to
standard operating procedures of Feingold and Martin
[19]. Urine samples were inoculated on cystine lysine
electrolyte deficient [CLED] agar and blood agar plates
[Oxoid Basingstoke, UK] using standard wire loop
[0.001 ml]. The inoculated agar plates were incubated at
37°C for 24 -48 hours. Then, the growths were inspected
to identify the bacteria. Biochemical tests were performed
on colonies from primary cultures for final identification
of the isolates. In brief, Gram-negative bacteria were iden-
tified by performing a series of biochemical tests (Oxoid,
LTD), namely triple sugar iron agar, indole, Simon’s citrate
agar, lysine iron agar, urea, mannitol and motility.
Gram-positive bacteria were identified based on their
gram reaction, noviobiocin, catalase and coagulase test
results.
The antimicrobial susceptibility tests of the isolates
were performed according to the national committee for
clinical laboratory standards (NCCLS) method using Kibry-
Bauer disk diffusion test on Mueller-Hinton agar. Results
were interpreted after measuring the zone of inhibition and
comparing with the standards. Eshercia coli ATCC 25922
and S. aureus ATCC 25923 were employed as quality con-
trols for the antimicrobial susceptibility test [20]. Finally
data were edited, coded, and entered into SPSS Windows
version 16.0, and descriptive statistics was computed to
meet the stated objective.
Ethical considerations
Ethical clearance was obtained from ethical review com-
mittee of Wollo University. The head of laboratory was
requested for cooperation/permission by a formal letter
from Wollo University. Patient privacy was protected by
de-identification of records. Names of patients were re-
placed by initials. All data obtained in the course of the
study were kept confidential, and used solely for the pur-
pose of the study.
Results
Demographic characteristics of patients and tests
performed
About 2486 culture results from urinary tract discharges
and urine during the ten years period were included in
the study. A majority of samples 1694 (68.1%) were from
females, and 1373 (55.2%) were under age group of
Table 2 Distribution of samples in years in Dessie
regional health research laboratory, May, 2012
S. No Year Samples (%)
1 2002 317 (12.8)
2 2003 323 (13.0)
3 2004 357 (14.4)
4 2005 266 (10.7)
5 2006 234 (9.4)
6 2007 285 (11.5)
7 2008 201 (8.1)
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and 218 (8.8%) of samples respectively (Table 1).
Urine 2007 (80.7%) and vaginal discharge 395(15.9%)
were the most commonly used samples for culture,
while, urethral discharge being used in 84 (3.37%) cases.
The number of samples cultured in each year tended
to decrease over time. Thus, majority of samples were
analyzed in between 2002-2004 G.C (12-14%), whereas,
least number was during 2009-2011 G.C (5-8%). Majority
of bacteria 71 (35.86%) were isolated in 2011 G.C but only
41 (17.52%) were isolated in 2006 G.C (Table 2, Figure 1).8 2009 177 (7.1)
9 2010 128 (5.1)
10 2011 198 (8.0)
11 Total 2486 (100)Prevalence and common types of bacterial uropathogens
isolated
About 680 (27.35%) bacteria were isolated from 2486
cultures. The most commonly isolated bacteria were E.
coli 410 (60.29%) followed by Pseudomonas species 59
(8.68%), Proteus species 53 (7.79%), S. aurous 50 (7.35%)
and Klebsiella species 40 (5.88%), respectively. Neverthe-
less, from the total positive samples of the patients about
21 (3.09%) of results were reported as ‘pathogenic mi-
croorganisms detected’, means the lab personnel were
unable to identify the species of the microorganisms de-
tected (Figure 2). About 528 (77.65%) and 372 (54.71%)
of bacteria were isolated from females and in age group
of 16-35 years respectively.
Approximately a quarter of the E.coli isolates were
resistant to Amoxicillin, Ampicillin, tetracycline, and
Trimetoprim-sulphamethoxazole (TMP-SMX) but were
susceptible to Chloramphenicol, Ceftriaxone, Ciprofloxacin,
Gentamicin, Kanamycin and Nalidixic acid. Antimicrobial
susceptibility results are summarized in (Table 3).Table 1 Sex distribution of patients in the Dessie regional
health research laboratory, May, 2012
S. No Patient characteristics Frequency (%)
Sex of patients





Not mentioned 218 (8.8)




> = 51 195 (7.8)
Total 2486 (100)Discussion
According to this study out-off 680 [27.35%] cultures at
least one bacterial species was isolated. The majority 528
(77.65%) were from females, and 372 (54.71%) from pa-
tients of 16-35 years old. This supports the idea women
are more prone UTIs [1,3,5,21]. Likewise, UTIs were more
common among women of reproductive age groups (16-
35 years) which agrees with earlier studies in this country
and abroad in Nigeria, India and Kuwait [21-26] identified
sexually active and/or probably pregnant females in this
age group are at high risk for UTI.
The prevalence of isolated bacteria 680 [27.35%] were
higher in this study compared with similar studies in the
country [23 -25,36]. This might be due to data in this
study were collected from culture results of patients re-
ferred for diagnostic purpose which will select for infected
cases with gram-negatives 598 [87.94%] bacteria, which
were most commonly isolated in this study. This preva-
lence differs with studies in other parts of the country
[23,24,27] and other countries like Kuwait, Nigeria and
Tanzania [6,28,29]. This might be due to geographical
and/or methodological differences as well large site
coverage, difference in source of data, laboratory verses
hospitals, from other studies done in Ethiopia or other
countries.
In this study like many other similar studies, E. coli re-
main the most prominent uropathogens which was iso-
lated in 60.29% of the cultures. This is consistent with
other studies in Ethiopia and abroad though the figure
is slightly higher in this study [30-32]. Among the other
frequently isolated bacterial uropathogens the most
common were Pseudomonas species [8.68%], Proteus
species [7.79%], S.aurous [7.35%] and Klebsiella species
[5.88%]. This is similar when compared with other studies
in Ethiopia and outside Ethiopia [23,24,27-29].
This study has showed that approximately a quarter of






























Years of UTI test done
Figure 1 Distribution of isolated bacteria per year in Dessie regional laboratory, May 2012.
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SMX]. But were relatively sensitive to chloramphenicol,
Ceftriaxone, Ciprofloxacin, Gentamycin, Kanamycin and
Nalidixic Acid. This was partially in agreement with other
studies in other parts of Ethiopia [23,24,27,33] but was
comparable with a report from Nigeria [6,25]. The dif-
ference might be attributed to methodology, and pattern
of management [34,35]. In the study area there are
many private pharmacies, hospitals and clinics which
might have contributed to overuse of antibiotics and
self-medication resulting in drug resistance as reported
in earlier studies [14-16].
In comparison with the developed world the resistance
rate of E.coli was elevated for all antibiotic treatments that
have been used in the study area for the past ten years to
treat UTIs [36-38]. For example, in Europe Amoxicillin
resistance ranges 48% in Netherland to 60% in Belgium
and from 21% to 36% for the TMP-SMX, whereas in our
case it was 84.6% and 75.8%, respectively [39]. Hence, as
it has been indicated in various researches the reason for
difference might be factors related to poverty, although,Figure 2 Distribution of Isolated microorganisms in Dessie regional ladifference in antibiotic use, patient population and pre-
scribing rate can also play a role [36,40-42].
In this study most isolates of Gram-negative bacteria
were resistant to two or more drugs [multi-drug resist-
ance] similarly a reported for studies in other parts of the
country [24,27]. This indicates that multi-drug resistance
is increasingly becoming a major problem in the manage-
ment of uropathogens in Ethiopia. This raises alarms to
implement a nationwide antimicrobial surveillance and
in-vitro susceptibility testing with strict adherence to
antibiotic policy to inhibit the spread of drug resistant
microbes in the country. Moreover, considering antibi-
otics with a resistance level of 10% or less are suitable
for empiric therapy and the resistance level of antibi-
otics reported in this study were more than 10% for
most common causative agents for UTI. Thus, these anti-
biotics are no longer appropriate for emparic management
of UTIs. Hence, calls for nationwide study to know the
exact level of antibiotics resistance among pathogenic bac-
teria is vital to make the right recommendation of alterna-
tive antibiotics and to support expert opinion [43].boratory, May, 2012.
Table 3 Antibiotic Susceptibility pattern of isolated microorganisms in Dessie regional health research laboratory,
May, 2012






Entrobactor S. epidermidis N. gonorrhea Citrobactor
Tt %S Tt %S Tt %S Tt %S Tt %S Tt %S Tt %S Tt %S Tt %S
Amoxicillin 182 28(15.4) 8 1/8 14 0/14 3 1/3 20 6(30.0) 5 0/5 5 1/5 1 1/1 1 0/1
Tetracycline 314 56(17.8) 16 6(37.5) 23 6(26.1) 10 3/10 26 9(34.6) 19 8(42.1) 4 0/4 2 1/2 7 0/7
TMP-SMX 231 56(24.2) 27 9(33.3) 17 6(35.3) 15 4/15 23 8(34.8) 15 12/15 8 2/8 1 0/1 4 ¾
Cephalothin 71 41(57.7) 8 0/8 10 3/10 2 1/3 5 5/5 7 2/7 5 2/5 1 0/1 2 ½
Ampicillin 45 9(20.0) 3 1/3 4 0/4 1 0/1 8 1/8 1 0/1 1 0/1 2 2/2 1 0/1
Chloramphenicol 201 104(51.0 15 12/15 16 5(31.3) 7 4/7 21 13(61.9 19 13(68.4) 4 2/4 2 2/2 5 3/5
Ceftriaxone 196 104(53.1 15 10/15 14 614 14 8/14 23 11(47.8 15 11/15 2 2/2 2 2/2 3 2/3
Ciprofloxacin 92 66(71.7) 43 41(95.3) 10 9/1 18 11(61.1) 10 6/4 17 15(88.2) 4 ¾ 3 1/3 5 4/5
Doxycyclin 62 22(35.5) 10 2/10 7 2/7 3 2/3 7 4/7 1 1/1 - - - - 1 0/1
Erythromycin 125 7(5.6) 39 7(17.9) 17 4(23.5) 27 10(37.0) 11 1/11 14 3/14 4 2/4 2 2/2 6 0/6
Gentamicin 362 239(66.0) 18 13(72.2) 25 16(64.0) 7 4/7 35 20(57.1) 19 16(84.2) 5 4/5 3 2/3 6 0/6
Kanamycin 145 116(80.0) - - 8 5/8 1 0/1 4 2/4 1 0/1 - - - - 2 0/2
Naldixic acid 105 91(86.7) - - 8 5/8 - - 9 9/9
Nitrofurantoin 48 43(89.6) 4 4/4 4 4/4 3 3/3 6 4/6 6 5/6 - - 1 1/1 1 1/1
Penicillin G 2 ½ - - - - - - - - - - - - - - - -
Vancomycin 31 3(9.7) 9 1/9 3 0/3 3 0/3 1 0/1 - - - - - - 1 0/1
Furantoin 142 124(87.3) 1 0/1 13 5/13 1 1/1 24 16(66.7) 1 1/1 4 4/4
Carbencillin 127 42(33.1) 5 0/5 14 5/14 2 0/2 3 0/3 2 2/2 3 1/3 2 0/2
Clindamycin 26 16(61.5) 5 1/5 3 1/3 – - 1 0/1 3 2/3 - - - - 2 ½
Bacitracin 45 13(28.9) - - 7 2/7 - - 4 ¼ - - 1 0/1 - - -
Streptomycin 10 1/10 - - - - - - 5 2/5 - - - - - - - -
Oxacyclin 12 12/12 3 2/3 1 0/1 1 0/1 - - 4 4/4 1 0/1 - - 1 0/1
*Cut-off levels to establish sensitivity was done based on Oxoid the FDA susceptivity test interprative criteria available at: www.oxoid.com.
**Abbreviations: Tt Total tests, %S percent of sensitive results; for those samples ≤15 total sensitive/total tests (T
s/Tt) was used, TMP-SMX- trimetoprim-sulphamethoxazole,
spps species.
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population that live in South Wollo area since only those
who visited the health research laboratory either by re-
ferral or by patients own interest were included in the
study. Only those antibiotics tested in the regional health
research laboratory were included in the study. Thus, it
may not include all antibiotics used in clinical practice.
Being a retrospective study incomplete records and il-
legible hand writing eliminated some culture results and
antibiotics from the study.
Conclusion
In conclusion, the E. coli, pseudomonas and proteus
species were the three commonly isolated microorgan-
isms in the regional health research laboratory. More-
over, most isolated bacterial microbes were resistant to
antibiotics used in clinical practices in the country. This
calls for attention of health professionals and policy
makers to consider the resistance pattern in their clin-
ical practice, and policy making process respectively.
Most importantly, these data may be used to controltrends of antibiotic susceptibilities, to develop local anti-
biotic policies and to assist clinicians in the rational choice
of antibiotic therapy and thus, to prevent indiscriminate
use of antibiotics.
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